All News

In February 2019, EPSRC announced a £30 million investment in three new Manufacturing Research Hubs, including the Future Biomanufacturing Research Hub (FBRH). The FBRH will be led by Professor Nigel Scrutton and based at the Manchester Institute of Biotechnology (MIB), with ‘spokes’ at Imperial, UCL, Nottingham, the UK Catalysis Hub, IBioIC and CPI. (read more…)

On 4 February, the Engineering and Physical Sciences Research Council (EPSRC) revealed the successful university proposals for Centres for Doctoral Training (CDTs). The CDTs will be funded through EPSRC, which has allocated £444 million, with a further £2.2 million from The Natural Environment Research Council (NERC). Industry partners are contributing a further £386 million in cash or in-kind. (read more…)

FUJIFILM Diosynth Biotechnologies (Fujifilm), a leading Contract Development and Manufacturing Organization (CDMO) with experience in the development and manufacture of recombinant biopharmaceuticals and gene therapies, has announced the inception of the “FDB Centre of Excellence in Bioprocessing 2.0” (CEB) in the United Kingdom. This initiative is an extension of Fujifilm’s global innovation initiatives. (read more…)

BBSRC have granted a no-cost extension to BioProNET to enable the network to continue its activities until August 2019. A main aim of the extension is to investigate how to make the network sustainable in the long-term. BioProNET have been in discussion with key stakeholders in industry and academia but you are encouraged to get in touch if you would like to be involved:

Meetings are planned for later in the year; make sure you keep up to date with them via their website or twitter or sign up for their newsletters.

Read the full news story from BioProNET here

The Biorenewables Development Centre (BDC), a subsidiary of the University of York, has been awarded £1.5m by the European Regional Development Fund (ERDF). This fund will support Yorkshire businesses that deliver products, processes or services related to renewable, biological resources.

(read more…)

The Bio-Based Industries Joint Untertaking (BBI JU) is a public-private partnership between the European Union and the Bio-based Industries Consortium (BIC). BBI JU operates under Horizon 2020 and its scientific priorities are driven by the Strategic Innovation and Research Agenda (SIRA), published in March 2013 and updated in July 2017. (read more…)

In August 2017, a coalition of industry and charity partners, led by Professor Sir John Bell, published a report into the life sciences industry – Life Sciences: Industrial Strategy – setting out recommendations for the UK life sciences industry. The report outlined the significant competitive advantages the UK possesses, as well as areas where key developments could fix issues which have slowed down growth. In response to this report, the government published the first Life Sciences Sector Deal, a key component of the Industrial Strategy. (read more…)

Speciality chemicals company Croda International has announced the official launch and certification of its ECO range of bio-based surfactants – ingredients designed to meet increasing market demand for sustainable, high-performance ingredient options. (read more…)

BBSRC is now inviting applications for the annual awards that celebrate the best innovations arising from biological science research.

Each year the BBSRC Innovator of the Year awards recognise and reward individuals and small teams who have harnessed the potential of their excellent research. (read more…)

Building a low carbon future: £11m to fund Industrial Biotechnology and Bioenergy Networks

Moving to a low carbon economy in the coming decades requires a shift from using fossil resources to provide power, fuel, chemicals and materials. BBSRC, with the support of EPSRC, have committed £11 million to fund 6 unique collaborative Networks in Industrial Biotechnology and Bioenergy (BBSRC NIBB) to support, encourage, and facilitate this essential work. The Networks will run from 2019 to 2024, will provide flexible funding for Proof of Concept projects, and are open to new members throughout their lifetime. (read more…)

The first meeting of the independent Industrial Strategy Council took place on 1 November, led by the Chief Economist of the Bank of England, Andy Haldane. The group agreed how it will assess the government’s progress on the commitments made in the modern Industrial Strategy. (read more…)

We are pleased to announce that CBMNet member Dr Dan Mulvihill, along with co-investigator Jennifer Hiscock, both from the University of Kent, have been awarded a BBSRC ‘Stand-alone’ LINK grant to fund their ongoing collaboration with Fujifilm Diosynth Biotechnologies. Their partnership was initiated at a CBMNet network event and preliminary data was generated with CBMNet support from two CBMNet Business Interaction Vouchers. (read more…)

SynbiCITE launches new five-year strategy, whilst its founders and directors are recognised for their contribution. (read more…)

On 11 October 2018, the Commission has put forward an action plan to develop a sustainable and circular bioeconomy that serves Europe’s society, environment and economy.

(read more…)

On 6 June 2018, the Industrial Biotechnology Leadership Forum (IBLF) launches the new ‘National Industrial Biotechnology Strategy to 2030’, promoted in partnership with the UK BioIndustry Association (BIA). The Strategy has been developed by the IBLF and two collaborative networks in industrial biotech, CBMNet and BIOCATNET. (read more…)

We are pleased to confirm that UK Research and Innovation (UKRI), the Biotechnology and Biological Science Research Council (BBSRC) has agreed to provide a grant of £233,222 to CBMNet to support Industrial Biotechnology Catalyst: Early Stage Feasibility Projects, provided through Wave 1 of the Industrial Strategy Challenge Fund (ISCF). (read more…)

BBSRC has identified industrial biotechnology and bioenergy as high-level priority areas in its Delivery Plan for 2016-2020. Supporting the BBSRC to achieve its strategic goals, this focused workshop will identify the science and technological barriers that need to be addressed in order to harness the potential of plant ‘cell factories’ for producing biopharmaceuticals. A CBMNet-driven symposium (Manchester, September 2017) brought together key players from Canada, the EU and the UK, to discuss scientific and commercial opportunities and challenges in this space. The goal now is to regroup, with a more focused set of individuals, to refine the landscape and to identify opportunities for collaborative R&D projects involving academia and industry in the UK and Canada. These aims are synergistic with those of CBMNet and IBCarb in the UK, and with the Canadian Glycomics Network, GlycoNet. (read more…)

Leave a Reply

Your email address will not be published. Required fields are marked *